Physician profile
Mark Dedvukaj
NPI 1427678341
$3,218.52
in general payments reported to CMS, 2019-2025
6 companies · $3,219 in 2025
The $3,219 reported for 2025 was more than what 91% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $3,219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,740 · Food and Beverage: $1,479.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,739.92 |
| Food and Beverage | $1,478.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,489.70 | 2025 | Proclaim, Durata |
| Spr Therapeutics, INC | $856.37 | 2025 | Sprint Pns System |
| Boston Scientific Corporation | $415.26 | 2025 | Wavewriter Alpha Prime 16, General - Therapies, General - Pain Management |
| Medtronic, INC. | $282.48 | 2025 | Inceptiv, Intellis Adaptivestim |
| Globus Medical, INC. | $157.58 | 2025 | Senza |
| Biotronik Nro, INC. | $17.13 | 2025 | Prospera |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Dedvukaj listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.